BMC Neuroscience, 2016 · DOI: 10.1186/s12868-016-0317-0 · Published: December 6, 2016
This study investigates gait abnormalities in a rat model of multiple sclerosis (MS) using the CatWalk XT system. The goal was to determine if this system could detect subtle, early-stage gait changes and if it could be used to assess treatment effectiveness. The researchers found that the CatWalk system did not detect any gait abnormalities before the onset of clinical symptoms in the rat model. However, they identified a combination of gait parameters that could predict the onset of the disease. The study suggests that while the CatWalk system may not be beneficial for detecting early-stage changes or evaluating treatments with significant effects, it could be useful in studies focused on nerve regeneration where subtle improvements in function need to be detected.
The CatWalk system may be a refined test to detect small but functional relevant changes in regeneration-orientated studies.
The CatWalk test indicates no benefit of lab-intensive automated gait system in EAE-model with chronic-progressive disease course.
CatWalk analysis should be combined with histopathological and electrophysiological studies to give a more accurate view of structure–function relations of disease processes in EAE.